Nordion Inc. (NDN)

Toronto
Currency in CAD
14.36
0.00(0.00%)
Real-time Data·
Showing Nordion Inc. historical data. For real-time data please try another search
Day's Range
14.0114.36
52 wk Range
0.0014.36
Key Statistics
Edit
Bid/Ask
14.16 / 14.36
Prev. Close
14.36
Open
14.06
Day's Range
14.01-14.36
52 wk Range
0-0
Volume
-
Average Volume (3m)
9.1K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Technical Indicators
Moving Averages

Nordion Inc. Company Profile

Nordion (Canada) Inc., a health science company, provides various products and services for the prevention, diagnosis, and treatment of diseases worldwide. The company operates in two segments: Sterilization technologies and medical isotopes. The Sterilization Technologies segment offers Cobalt-60, a radioactive metal that emits radiation and sterilizes items by destroying contaminating micro-organisms; dosimetry and professional services; as well as designs, constructs, and maintains commercial gamma sterilization systems. The Medical Isotopes segment provides various products that are used in the diagnosis and treatment of diseases, including cardiac and neurological conditions and various types of cancer. It offers Molybdenum-99, which decays into Technetium-99, a diagnostic that is used in nuclear medical procedures; Xenon-133, used in lung scans; Iodine-131, to treat hyperthyroidism, thyroid cancer, and non-Hodgkin’s lymphoma; Iodine-125, to treat prostate cancer; and Yttrium-90, to treat liver cancer and non-Hodgkin’s lymphoma. This segment also provides cyclotron isotopes, such as Iodine-123 to diagnose thyroid disease; Thallium-201 to diagnose and assess risk of coronary artery heart disease; Palladium-103 for treating prostate cancer; Strontium-82 for cardiac imaging; and Indium-111 and Gallium-67 to diagnose cancer, as well as offers radiopharmaceutical and contract manufacturing services. Nordion (Canada) Inc. serves radiopharmaceutical and pharmaceutical manufacturers, biotechnology companies, manufacturers of medical supplies and devices, contract sterilizers, hospitals, and academic and government institutions, as well as the food and consumer goods industries. The company was formerly known as MDS Inc. and changed its name to Nordion (Canada) Inc. in November 2010. Nordion (Canada) Inc. was incorporated in 1946 and is headquartered in Ottawa, Canada with an additional office in Abingdon, United Kingdom. As of August 6, 2014, Nordion (Canada) Inc. operates as a subsidiary of Sotera Health Company.

Employees
400
Market
Canada

Earnings

Latest Release
Jun 02, 2014
EPS / Forecast
0.11 / --
Revenue / Forecast
74.70M / --
EPS Revisions
Last 90 days

NDN Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.